Jump Financial, LLC Immatics N.V. Transaction History
Jump Financial, LLC
- $4.56 Billion
- Q3 2024
A detailed history of Jump Financial, LLC transactions in Immatics N.V. stock. As of the latest transaction made, Jump Financial, LLC holds 33,600 shares of IMTX stock, worth $286,608. This represents 0.01% of its overall portfolio holdings.
Number of Shares
33,600
Previous 48,991
31.42%
Holding current value
$286,608
Previous $569,000
32.69%
% of portfolio
0.01%
Previous 0.01%
Shares
15 transactions
Others Institutions Holding IMTX
# of Institutions
99Shares Held
75.6MCall Options Held
185KPut Options Held
611K-
Rtw Investments, LP New York, NY10MShares$85.3 Million1.82% of portfolio
-
Wellington Management Group LLP Boston, MA9.68MShares$82.6 Million0.02% of portfolio
-
Perceptive Advisors LLC New York, NY8.09MShares$69 Million2.41% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.38MShares$62.9 Million0.05% of portfolio
-
Baker Bros. Advisors LP New York, NY6.44MShares$55 Million0.79% of portfolio
About Immatics N.V.
- Ticker IMTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 76,227,000
- Market Cap $650M
- Description
- Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor (TCR) based immunotherapies for the treatment of cancer in the United States. The company is developing targeted immunotherapies with a focus on treating solid tumors through two distinct treatment modalities, such as adoptive c...